Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. Humacyte Inc leads the sector with a market cap of $145.07 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
Humacyte Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 601 |
Humacyte Inc
NASDAQ:HUMA |
$145.07 Million | $145.07 Million | USA | $0.65 | -2.71% | +2.32% | 202.07 Million |
| 602 |
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD |
$143.70 Million | $143.70 Million | USA | $6.60 | +3.12% | +3.29% | 8.91 Million |
| 603 |
Kangstem Biotech Co. Ltd
KQ:217730 |
$143.41 Million | ₩211.62 Billion | Korea | ₩2250.00 | +1.12% | +2.27% | 26.18 Million |
| 604 |
Oncolytics Biotech Inc
TO:ONC |
$142.51 Million | CA$197.01 Million | Canada | CA$14.90 | -1.32% | -19.89% | 4.73 Million |
| 605 |
PROQR THERAPEUTICS EO-04
F:0PQ |
$142.34 Million | €121.75 Million | Germany | €1.50 | +1.15% | -0.13% | 0.00 |
| 606 |
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP |
$142.20 Million | $142.20 Million | USA | $10.01 | -0.79% | -5.74% | 11.85 Million |
| 607 |
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK |
$141.39 Million | $141.39 Million | USA | $3.85 | +0.00% | +0.52% | 11.79 Million |
| 608 |
TIZIANA LIFE SCIENCES LTD
F:0RP |
$141.34 Million | €120.90 Million | Germany | €0.95 | -2.56% | -9.52% | 68.00K |
| 609 |
Agenus Inc
NASDAQ:AGEN |
$141.17 Million | $141.17 Million | USA | $7.50 | -5.18% | +21.16% | 220.65 Million |
| 610 |
Prelude Therapeutics Inc
NASDAQ:PRLD |
$140.19 Million | $140.19 Million | USA | $4.60 | -8.91% | +17.05% | 9.51 Million |
| 611 |
Orthocell Ltd
AU:OCC |
$140.14 Million | AU$198.05 Million | Australia | AU$0.73 | +3.55% | +2.10% | 8.89 Million |
| 612 |
Genovis AB (publ.)
ST:GENO |
$139.20 Million | Skr1.29 Billion | Sweden | Skr19.58 | -0.71% | +2.94% | 1.16 Million |
| 613 |
TuHURA Biosciences Inc
NASDAQ:HURA |
$138.19 Million | $138.19 Million | USA | $2.17 | +0.00% | +0.93% | 8.20 Million |
| 614 |
Medigen Biotechnology
TWO:3176 |
$136.72 Million | NT$4.34 Billion | Taiwan | NT$31.15 | +0.16% | -7.29% | 15.30 Million |
| 615 |
Tenaya Therapeutics Inc
NASDAQ:TNYA |
$136.66 Million | $136.66 Million | USA | $0.74 | -1.29% | -4.24% | 56.12 Million |
| 616 |
Caribou Biosciences Inc
NASDAQ:CRBU |
$136.46 Million | $136.46 Million | USA | $1.46 | -3.31% | -10.43% | 42.84 Million |
| 617 |
Vytrus Biotech S.A.
MC:VYT |
$135.30 Million | €115.73 Million | Spain | €17.00 | +0.00% | -2.02% | 459.96K |
| 618 |
Unicycive Therapeutics Inc
NASDAQ:UNCY |
$133.77 Million | $133.77 Million | USA | $5.01 | -5.47% | -8.24% | 52.07 Million |
| 619 |
Corbus Pharmaceuticals Holding
NASDAQ:CRBP |
$133.75 Million | $133.75 Million | USA | $8.97 | -0.88% | -3.76% | 7.54 Million |
| 620 |
ADC Therapeutics SA
NYSE:ADCT |
$133.55 Million | $133.55 Million | USA | $1.05 | -5.41% | -13.93% | 25.69 Million |
| 621 |
Heidelberg Pharma AG
F:HPHA |
$133.46 Million | €114.15 Million | Germany | €2.44 | -3.94% | -2.40% | 0.00 |
| 622 |
Innate Pharma
NASDAQ:IPHA |
$133.24 Million | $133.24 Million | USA | $1.75 | +0.29% | -0.57% | 184.68K |
| 623 |
MOLECULAR PARTNERS ADS/1
F:6ML0 |
$133.19 Million | €113.92 Million | Germany | €3.54 | -3.80% | +0.00% | 17.40K |
| 624 |
Vaxart Inc
NASDAQ:VXRT |
$132.84 Million | $132.84 Million | USA | $0.55 | +5.58% | +13.20% | 3.84 Million |
| 625 |
Genelux Corporation Common Stock
NASDAQ:GNLX |
$131.83 Million | $131.83 Million | USA | $2.94 | -3.61% | -0.68% | 4.13 Million |
| 626 |
VYTRUS BIOTECH EO -01
F:V5P |
$131.54 Million | €112.51 Million | Germany | €16.60 | +0.61% | -1.19% | 110.00 |
| 627 |
Fate Therapeutics Inc
NASDAQ:FATE |
$131.50 Million | $131.50 Million | USA | $2.45 | -2.39% | -2.78% | 71.72 Million |
| 628 |
Tiziana Life Sciences Ltd
NASDAQ:TLSA |
$131.08 Million | $131.08 Million | USA | $1.03 | +6.19% | +0.98% | 6.00 Million |
| 629 |
Tharimmune Inc.
NASDAQ:THAR |
$130.84 Million | $130.84 Million | USA | $3.31 | -5.70% | +0.00% | 15.04 Million |
| 630 |
Alpha Cognition Inc
NASDAQ:ACOG |
$127.19 Million | $127.19 Million | USA | $8.28 | -5.15% | +0.61% | 2.28 Million |
| 631 |
Connect Biopharma Holdings Ltd
NASDAQ:CNTB |
$127.19 Million | $127.19 Million | USA | $2.02 | -3.35% | -8.18% | 11.64 Million |
| 632 |
Equillium Inc
NASDAQ:EQ |
$126.05 Million | $126.05 Million | USA | $2.20 | -5.17% | -18.22% | 22.66 Million |
| 633 |
Nautilus Biotechnology Inc
NASDAQ:NAUT |
$123.40 Million | $123.40 Million | USA | $0.98 | -5.15% | -44.80% | 24.23 Million |
| 634 |
Xlife Sciences AG
SW:XLS |
$122.27 Million | CHF96.71 Million | Switzerland | CHF16.85 | -0.88% | -1.46% | 113.81K |
| 635 |
PepGen Ltd
NASDAQ:PEPG |
$121.74 Million | $121.74 Million | USA | $1.76 | -1.12% | -16.19% | 24.55 Million |
| 636 |
Seer Inc
NASDAQ:SEER |
$120.96 Million | $120.96 Million | USA | $2.22 | +7.77% | +8.29% | 59.63 Million |
| 637 |
InflaRx N.V
F:IF0 |
$120.35 Million | €102.95 Million | Germany | €1.42 | -5.07% | -6.19% | 3.80K |
| 638 |
vTv Therapeutics Inc
NASDAQ:VTVT |
$119.97 Million | $119.97 Million | USA | $32.35 | -1.01% | +2.18% | 2.14 Million |
| 639 |
enGene Holdings Inc. Common Stock
NASDAQ:ENGN |
$119.91 Million | $119.91 Million | USA | $1.79 | +1.70% | -5.29% | 22.22 Million |
| 640 |
Inhibikase Therapeutics Inc
NASDAQ:IKT |
$119.23 Million | $119.23 Million | USA | $2.18 | -4.39% | -6.44% | 23.81 Million |
| 641 |
INNATE PHARMA SP.ADR/1
F:IDDA |
$116.15 Million | €99.35 Million | Germany | €1.06 | -9.40% | -26.90% | 6.23K |
| 642 |
Nykode Therapeutics ASA
OL:NYKD |
$116.14 Million | Nkr1.10 Billion | Norway | Nkr3.38 | -3.98% | +9.92% | 14.14 Million |
| 643 |
Leap Therapeutics Inc
NASDAQ:LPTX |
$116.14 Million | $116.14 Million | USA | $2.05 | +368.57% | +391.14% | 817.45 Million |
| 644 |
Spruce Biosciences, Inc. Common Stock
NASDAQ:SPRB |
$115.74 Million | $115.74 Million | USA | $42.83 | -1.25% | -4.80% | 1.56 Million |
| 645 |
Innate Pharma
PA:IPH |
$115.22 Million | €98.56 Million | France | €1.53 | -1.67% | -2.92% | 2.81 Million |
| 646 |
Genovate Biotechnology Co Ltd
TWO:4130 |
$115.03 Million | NT$3.65 Billion | Taiwan | NT$26.70 | -0.37% | -5.15% | 4.08 Million |
| 647 |
Repare Therapeutics Inc
NASDAQ:RPTX |
$114.24 Million | $114.24 Million | USA | $2.65 | +0.76% | +2.71% | 37.69 Million |
| 648 |
Codexis Inc
NASDAQ:CDXS |
$112.91 Million | $112.91 Million | USA | $1.40 | -5.41% | -29.65% | 29.80 Million |
| 649 |
Captor Therapeutics S.A.
WAR:CTX |
$112.49 Million | zł408.75 Million | Poland | zł74.20 | +0.00% | +0.27% | 64.66K |
| 650 |
Nyrada Inc
AU:NYR |
$110.92 Million | AU$156.77 Million | Australia | AU$0.64 | +15.32% | +15.32% | 7.40 Million |
| 651 |
SynAct Pharma AB
ST:SYNACT |
$110.04 Million | Skr1.02 Billion | Sweden | Skr18.26 | +2.47% | -1.30% | 6.35 Million |
| 652 |
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX |
$109.36 Million | $109.36 Million | USA | $2.31 | +7.44% | +9.48% | 2.74 Million |
| 653 |
Alterity Therapeutics Ltd
AU:ATH |
$108.75 Million | AU$153.70 Million | Australia | AU$0.55 | +2.83% | -5.22% | 5.42 Million |
| 654 |
Fractyl Health, Inc. Common Stock
NASDAQ:GUTS |
$108.67 Million | $108.67 Million | USA | $0.69 | -0.72% | -9.48% | 42.59 Million |
| 655 |
NIBEC Co. Ltd
KQ:138610 |
$105.62 Million | ₩155.85 Billion | Korea | ₩13710.00 | +12.38% | -6.48% | 638.31K |
| 656 |
Arcticzymes Technologies ASA
OL:AZT |
$105.33 Million | Nkr1.00 Billion | Norway | Nkr19.60 | +0.51% | -2.49% | 614.54K |
| 657 |
Hillevax Inc
NASDAQ:HLVX |
$104.76 Million | $104.76 Million | USA | $2.09 | +0.00% | -0.48% | 19.87 Million |
| 658 |
Dimerix Ltd
AU:DXB |
$104.08 Million | AU$147.10 Million | Australia | AU$0.25 | -2.00% | +2.08% | 50.67 Million |
| 659 |
OBI Pharma
TWO:4174 |
$104.05 Million | NT$3.30 Billion | Taiwan | NT$25.10 | +0.80% | -9.55% | 12.36 Million |
| 660 |
Active Biotech AB
ST:ACTI |
$103.60 Million | Skr962.66 Million | Sweden | Skr5.16 | -0.39% | +1.18% | 1.17 Million |
| 661 |
Vivani Medical Inc.
NASDAQ:VANI |
$103.48 Million | $103.48 Million | USA | $1.28 | -1.54% | -7.91% | 21.63 Million |
| 662 |
Sagittarius Life Science
TWO:3205 |
$101.30 Million | NT$3.22 Billion | Taiwan | NT$47.60 | -0.31% | -4.80% | 2.41 Million |
| 663 |
SYN-Tech Chem & Pharm Co Ltd
TWO:1777 |
$101.29 Million | NT$3.22 Billion | Taiwan | NT$72.10 | +0.14% | -1.10% | 1.08 Million |
| 664 |
MEI Pharma Inc
NASDAQ:MEIP |
$100.81 Million | $100.81 Million | USA | $3.07 | +10.43% | -36.70% | 26.47 Million |
| 665 |
CANBRIDGE PHARM.DL-00001
F:MF1 |
$99.19 Million | €84.85 Million | Germany | €0.17 | +0.00% | -1.19% | 0.00 |
| 666 |
STARPHARMA HLDG.SP.ADR/10
F:PQ6A |
$99.13 Million | €84.79 Million | Germany | €4.40 | -3.51% | +20.22% | 0.00 |
| 667 |
Digital Aria Co Ltd
KQ:115450 |
$98.99 Million | ₩146.07 Billion | Korea | ₩1657.00 | +9.01% | -4.55% | 16.69 Million |
| 668 |
Apex Biotechnology Corp
TW:1733 |
$98.56 Million | NT$3.13 Billion | Taiwan | NT$31.30 | -1.42% | -1.11% | 5.54 Million |
| 669 |
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA |
$98.29 Million | $98.29 Million | USA | $4.19 | +2.70% | -4.34% | 6.13 Million |
| 670 |
Cibus Global LLC
NASDAQ:CBUS |
$97.17 Million | $97.17 Million | USA | $1.93 | +0.00% | +8.43% | 10.13 Million |
| 671 |
KNOTUS Co.Ltd
KQ:278650 |
$96.91 Million | ₩143.01 Billion | Korea | ₩1693.00 | +6.95% | -6.41% | 4.80 Million |
| 672 |
Black Diamond Therapeutics Inc
NASDAQ:BDTX |
$96.84 Million | $96.84 Million | USA | $1.69 | -1.46% | -8.15% | 26.89 Million |
| 673 |
Adverum Biotechnologies Inc
NASDAQ:ADVM |
$96.26 Million | $96.26 Million | USA | $4.36 | +0.00% | +3.81% | 11.22 Million |
| 674 |
Immunoprecise Antibodies Ltd
NASDAQ:IPA |
$95.54 Million | $95.54 Million | USA | $2.07 | +7.25% | -25.00% | 38.78 Million |
| 675 |
Biosolution Co.Ltd
KQ:086820 |
$95.34 Million | ₩140.68 Billion | Korea | ₩5830.00 | +1.75% | -3.16% | 1.84 Million |
| 676 |
Milestone Pharmaceuticals Inc
NASDAQ:MIST |
$94.54 Million | $94.54 Million | USA | $1.11 | -3.48% | -7.50% | 29.91 Million |
| 677 |
Heron Therapeuti
NASDAQ:HRTX |
$93.92 Million | $93.92 Million | USA | $0.50 | -0.24% | +8.10% | 59.25 Million |
| 678 |
Infant Bacterial Therapeutics AB (publ)
ST:IBT-B |
$93.86 Million | Skr872.22 Million | Sweden | Skr67.00 | +2.13% | +2.13% | 110.11K |
| 679 |
GREEN CROSS WellBeing Corporation
KQ:234690 |
$93.80 Million | ₩138.41 Billion | Korea | ₩7800.00 | +7.59% | -3.11% | 2.05 Million |
| 680 |
Ryvu Therapeutics SA
WAR:RVU |
$93.79 Million | zł340.79 Million | Poland | zł14.74 | -1.21% | -2.51% | 819.92K |
| 681 |
Aldeyra The
NASDAQ:ALDX |
$92.65 Million | $92.65 Million | USA | $1.54 | -3.75% | -0.65% | 36.03 Million |
| 682 |
Actinogen Medical Ltd
AU:ACW |
$92.21 Million | AU$130.32 Million | Australia | AU$0.04 | +0.00% | -2.38% | 71.08 Million |
| 683 |
Rallybio Corp
NASDAQ:RLYB |
$91.81 Million | $91.81 Million | USA | $15.93 | -0.87% | -2.81% | 920.56K |
| 684 |
Q32 Bio Inc
NASDAQ:QTTB |
$91.06 Million | $91.06 Million | USA | $15.68 | +0.77% | +1.95% | 53.90 Million |
| 685 |
Adocia
PA:ADOC |
$90.58 Million | €77.48 Million | France | €3.96 | -0.95% | +3.66% | 2.79 Million |
| 686 |
NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ:NTHI |
$90.50 Million | $90.50 Million | USA | $3.49 | +0.00% | -3.86% | 1.55 Million |
| 687 |
Bioton S.A.
WAR:BIO |
$90.03 Million | zł327.14 Million | Poland | zł3.81 | -0.52% | -0.91% | 521.56K |
| 688 |
BIOCELTIX S.A. ZY -10
F:XI3 |
$89.73 Million | €76.75 Million | Germany | €20.40 | +6.36% | +10.39% | 0.00 |
| 689 |
Verrica Pharmaceuticals Inc
NASDAQ:VRCA |
$89.67 Million | $89.67 Million | USA | $5.22 | -0.76% | -4.04% | 743.07K |
| 690 |
Synergy Innovation Co. Ltd
KQ:048870 |
$89.26 Million | ₩131.72 Billion | Korea | ₩1495.00 | +3.46% | -3.05% | 11.08 Million |
| 691 |
Intech Biopharm Ltd
TWO:6461 |
$88.22 Million | NT$2.80 Billion | Taiwan | NT$15.70 | +2.61% | -1.26% | 5.62 Million |
| 692 |
ImmuCell Corporation
NASDAQ:ICCC |
$88.12 Million | $88.12 Million | USA | $11.21 | +1.36% | +2.56% | 744.79K |
| 693 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$87.01 Million | $87.01 Million | USA | $0.80 | +0.00% | +63.27% | 80.93 Million |
| 694 |
Pyxis Oncology Inc
NASDAQ:PYXS |
$86.55 Million | $86.55 Million | USA | $2.65 | -7.67% | -1.12% | 30.88 Million |
| 695 |
XSpray Pharma AB
ST:XSPRAY |
$86.13 Million | Skr800.39 Million | Sweden | Skr16.88 | +1.44% | +8.34% | 1.09 Million |
| 696 |
Darwin AG
XETRA:7V0 |
$85.58 Million | €73.20 Million | Germany | €6.10 | -4.69% | -8.27% | 59.29K |
| 697 |
Pelthos Therapeutics Inc.
NYSE MKT:PTHS |
$85.55 Million | $85.55 Million | USA | $26.66 | -1.62% | -3.72% | 583.37K |
| 698 |
Neuraxis, Inc.
NYSE MKT:NRXS |
$84.91 Million | $84.91 Million | USA | $7.38 | -0.67% | -11.62% | 4.63 Million |
| 699 |
Biomea Fusion Inc
NASDAQ:BMEA |
$84.59 Million | $84.59 Million | USA | $1.17 | -4.10% | -7.14% | 18.69 Million |
| 700 |
Bonus Biogroup
TA:BONS |
$84.54 Million | ILA31.53 Billion | Israel | ILA27.00 | +4.25% | -2.17% | 34.01 Million |
| 701 |
Anixa Biosciences Inc
NASDAQ:ANIX |
$84.38 Million | $84.38 Million | USA | $3.42 | -3.93% | -8.80% | 7.04 Million |
| 702 |
OSE Pharma SA
PA:OSE |
$84.03 Million | €71.88 Million | France | €3.21 | -0.06% | +0.19% | 3.32 Million |
| 703 |
Immutep Ltd ADR
NASDAQ:IMMP |
$84.03 Million | $84.03 Million | USA | $0.57 | -3.65% | +4.94% | 807.12 Million |
| 704 |
Kalaris Therapeutics, Inc.
NASDAQ:KLRS |
$83.51 Million | $83.51 Million | USA | $3.51 | +0.86% | -10.46% | 13.36 Million |
| 705 |
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELO |
$83.22 Million | $83.22 Million | USA | $1.21 | -3.20% | +4.31% | 2.23 Million |
| 706 |
Helix BioPharma Corp.
TO:HBP |
$82.88 Million | CA$114.57 Million | Canada | CA$1.50 | +0.00% | +4.17% | 17.55K |
| 707 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
$82.80 Million | $82.80 Million | USA | $10.10 | -3.16% | -0.30% | 10.13 Million |
| 708 |
Fortress Biotech Inc
NASDAQ:FBIO |
$79.39 Million | $79.39 Million | USA | $3.13 | -4.86% | -8.75% | 13.21 Million |
| 709 |
VIVANI MED.INC. NEW O.N.
F:U5P |
$79.34 Million | €67.86 Million | Germany | €1.04 | +2.97% | -10.34% | 0.00 |
| 710 |
Sutro Biopharma
NASDAQ:STRO |
$79.09 Million | $79.09 Million | USA | $24.17 | -2.62% | +2.42% | 7.90 Million |
| 711 |
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762 |
$79.00 Million | NT$2.51 Billion | Taiwan | NT$32.60 | +1.24% | -5.51% | 7.99 Million |
| 712 |
Nanoform Finland Plc
HE:NANOFH |
$78.90 Million | €67.49 Million | Finland | €0.86 | -1.26% | +3.35% | 1.04 Million |
| 713 |
Cognition Therapeutics Inc
NASDAQ:CGTX |
$78.53 Million | $78.53 Million | USA | $0.89 | -2.88% | -7.35% | 27.97 Million |
| 714 |
Recce Pharmaceuticals Ltd
AU:RCE |
$78.40 Million | AU$110.80 Million | Australia | AU$0.37 | -1.33% | +2.78% | 6.53 Million |
| 715 |
Brii Biosciences Limited
F:7SS |
$77.99 Million | €66.71 Million | Germany | €0.09 | -2.12% | -6.57% | 0.00 |
| 716 |
PolyPid
NASDAQ:PYPD |
$77.73 Million | $77.73 Million | USA | $4.29 | -1.83% | +1.18% | 7.98 Million |
| 717 |
Aerovate Therapeutics Inc
NASDAQ:AVTE |
$77.68 Million | $77.68 Million | USA | $2.68 | +0.00% | +0.00% | 1.03 Million |
| 718 |
MAIA Biotechnology Inc.
NYSE MKT:MAIA |
$77.66 Million | $77.66 Million | USA | $1.28 | +0.00% | -5.88% | 12.98 Million |
| 719 |
GlycoNex
TWO:4168 |
$77.61 Million | NT$2.46 Billion | Taiwan | NT$22.25 | +0.91% | -4.51% | 5.47 Million |
| 720 |
Abionyx Pharma SA
PA:ABNX |
$76.55 Million | €65.48 Million | France | €1.86 | -2.62% | -7.66% | 2.95 Million |
| 721 |
Genexine Inc
KQ:095700 |
$75.97 Million | ₩112.11 Billion | Korea | ₩2465.00 | +5.34% | +1.44% | 2.44 Million |
| 722 |
Rani Therapeutics Holdings Inc
NASDAQ:RANI |
$75.51 Million | $75.51 Million | USA | $0.77 | -5.63% | -13.02% | 23.25 Million |
| 723 |
ONDINE BIOMEDICAL INC.CDI
F:VF5 |
$75.33 Million | €64.44 Million | Germany | €0.14 | +0.00% | +0.00% | 0.00 |
| 724 |
AlzeCure Pharma
ST:ALZCUR |
$75.19 Million | Skr698.68 Million | Sweden | Skr6.08 | -3.49% | -4.40% | 19.84 Million |
| 725 |
Shanghai Haohai Biological Technology Co. Ltd
F:5HB |
$74.52 Million | €63.74 Million | Germany | €1.78 | -0.56% | +0.00% | 0.00 |
| 726 |
Champions Oncology Inc
NASDAQ:CSBR |
$74.43 Million | $74.43 Million | USA | $5.36 | +1.90% | -10.67% | 209.65K |
| 727 |
Island Pharmaceuticals Ltd
AU:ILA |
$74.24 Million | AU$104.93 Million | Australia | AU$0.39 | +1.30% | -7.14% | 9.97 Million |
| 728 |
Eyenovia Inc
NASDAQ:EYEN |
$73.30 Million | $73.30 Million | USA | $14.36 | +0.00% | +0.00% | 1.32 Million |
| 729 |
Gain Therapeutics Inc
NASDAQ:GANX |
$71.66 Million | $71.66 Million | USA | $1.68 | -4.55% | -7.69% | 31.08 Million |
| 730 |
ORIENTBIO Inc.
KO:002630 |
$71.52 Million | ₩105.54 Billion | Korea | ₩890.00 | +4.71% | -9.18% | 9.35 Million |
| 731 |
Alterity Therapeutics Ltd
NASDAQ:ATHE |
$70.69 Million | $70.69 Million | USA | $4.42 | -1.78% | -5.86% | 414.97K |
| 732 |
Adicet Bio Inc
NASDAQ:ACET |
$70.58 Million | $70.58 Million | USA | $9.11 | +0.55% | +8.19% | 2.27 Million |
| 733 |
Lytix Biopharma AS
OL:LYTIX |
$70.40 Million | Nkr669.03 Million | Norway | Nkr8.70 | -0.68% | -6.05% | 503.68K |
| 734 |
Coeptis Therapeutics Inc
NASDAQ:COEP |
$68.21 Million | $68.21 Million | USA | $16.40 | +1.17% | +19.62% | 1.29 Million |
| 735 |
XBiotech Inc
NASDAQ:XBIT |
$67.99 Million | $67.99 Million | USA | $2.23 | -0.45% | -2.19% | 952.14K |
| 736 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$67.74 Million | $67.74 Million | USA | $1.17 | -2.50% | +0.86% | 48.22 Million |
| 737 |
LeonaBio, Inc.
NASDAQ:LONA |
$66.32 Million | $66.32 Million | USA | $7.06 | -3.16% | -2.49% | 851.24K |
| 738 |
MediciNova Inc
NASDAQ:MNOV |
$65.36 Million | $65.36 Million | USA | $1.33 | -0.75% | +1.53% | 1.26 Million |
| 739 |
Alterity Therapeutics Limited
F:PBN |
$65.25 Million | €55.81 Million | Germany | €0.31 | +3.97% | -4.85% | 1.00 |
| 740 |
Oncopeptides AB
ST:ONCO |
$64.89 Million | Skr602.98 Million | Sweden | Skr1.58 | -0.13% | -0.38% | 30.52 Million |
| 741 |
Kazia Therapeutics Ltd ADR
NASDAQ:KZIA |
$64.84 Million | $64.84 Million | USA | $11.82 | +2.52% | +18.20% | 5.85 Million |
| 742 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
$64.40 Million | $64.40 Million | USA | $1.04 | -1.89% | -3.70% | 15.16 Million |
| 743 |
Entera Bio Ltd
NASDAQ:ENTX |
$64.20 Million | $64.20 Million | USA | $2.99 | +1.36% | +40.38% | 97.60 Million |
| 744 |
Rein Therapeutics Inc
NASDAQ:RNTX |
$63.08 Million | $63.08 Million | USA | $0.74 | -3.98% | -7.84% | 10.65 Million |
| 745 |
ENTERA BIO IS-0000769
F:5DT |
$61.53 Million | €52.63 Million | Germany | €2.60 | +3.17% | +50.29% | 0.00 |
| 746 |
Paradigm Biopharmaceuticals Ltd
AU:PAR |
$61.35 Million | AU$86.70 Million | Australia | AU$0.17 | +3.13% | -5.71% | 33.22 Million |
| 747 |
Maat Pharma SA
PA:MAAT |
$60.94 Million | €52.13 Million | France | €2.78 | -0.54% | +3.35% | 1.04 Million |
| 748 |
Annovis Bio Inc
NYSE:ANVS |
$60.63 Million | $60.63 Million | USA | $1.75 | -1.13% | +0.00% | 18.67 Million |
| 749 |
ImmunoPrecise Antibodies Ltd.
NASDAQ:HYFT |
$60.23 Million | $60.23 Million | USA | $1.29 | -4.44% | +9.32% | 6.45 Million |
| 750 |
Ikena Oncology Inc
NASDAQ:IKNA |
$59.90 Million | $59.90 Million | USA | $1.43 | +0.00% | +0.00% | 457.26K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries